Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration.

  title={Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration.},
  author={Rong Liu and Tian Wang and Bao Zhang and Li Qin and Chang-rui Wu and Qingshan Li and Le Ma},
  journal={Investigative ophthalmology \& visual science},
  volume={56 1},
PURPOSE To evaluate the effects of lutein and zeaxanthin on visual function in randomized controlled trials (RCTs) of AMD patients. METHODS Relevant studies were identified by searches on PubMed, EMBASE, Web of Science, and Cochrane Library database up to April 2014. Three investigators independently determined the eligibility of RCTs, which compared lutein and zeaxanthin intervention with placebo. The adjusted weighted mean differences (WMDs) from each study were extracted to calculate a… 

Figures and Tables from this paper

Effect of lutein supplementation on visual function in nonproliferative diabetic retinopathy.

In patients with NPDR, supplementation with lutein resulted in potential improvements in CS at low spatial frequency, and the possibility that such intervention could be used as an adjunct therapy to prevent vision loss in diabetic patients is considered.

A Randomized Study of Nutritional Supplementation in Patients with Unilateral Wet Age-Related Macular Degeneration

In patients with unilateral wet AMD, the addition of lutein, zeaxanthin, resveratrol, hydroxytyrosol and DHA to the AREDS EU recommended doses in the short-term did not have a differential effect on visual acuity compared to a standard AREDs EU formula, but may provide a beneficial effect in improving the proinflammatory and proangiogenic profile of patients with AMD.

Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease

This paper attempts to review the epidemiological studies and clinical trials investigating the effects of xanthophylls on the incidence and progression of various eye diseases and reports encouraging results.

The Impact of Supplemental Antioxidants on Visual Function in Nonadvanced Age-Related Macular Degeneration: A Head-to-Head Randomized Clinical Trial.

Antioxidant supplementation in patients with nonadvanced age-related macular degeneration results in significant increases in macular pigment and improvements in CS and other measures of visual function.

An exploratory study evaluating the effects of macular carotenoid supplementation in various retinal diseases

Assessing the impact of daily oral supplementation with Macushield on eye health in patients with retinal diseases by assessing the macular pigment profile, the visual function, and the quality of life found Supplementation with the three carotenoids enhances certain aspects of visual performance in retinal disease.

Lutein and Zeaxanthin—Food Sources, Bioavailability and Dietary Variety in Age-Related Macular Degeneration Protection

Diet models outlined provide information about the importance of diet variety among people at high risk of AMD or with early signs and symptoms of AMD, and describe important food sources and factors that increase the bioavailability of L/Z, to inform dietary models.

Macular carotenoid supplementation and visual function in early age-related macular degeneration

This thesis provides prevalence estimates of AMD in the ROI for the first time, and adds to the evidence with respect to the impact of macular carotenoid supplementation on visual function among patients with this condition.

Macular pigment optical density responses to different levels of zeaxanthin in patients with high myopia

Measurement of macular pigment optical density (MPOD) can be conducted to assist in the diagnosis of multiple fundus diseases. Fifty-four subjects with high myopia were prospectively recruited for a

Maternal Lutein and Zeaxanthin Concentrations in Relation to Offspring Visual Acuity at 3 Years of Age: The GUSTO Study

Maternal lutein and zeaxanthin status during pregnancy may influence offspring early visual development; but the results require confirmation with further studies, including more comprehensive measurements of macular functions.



Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.

Carotenoids in Age-Related Maculopathy Italian Study (CARMIS): Two-Year Results of a Randomized Study

Patients treated with lutein/zeAXanthin and astaxanthin together with other nutrients were more likely to report clinically meaningful stabilization/improvements in VA, CS, and visual function through 24 months compared with nontreated subjects.

Effect of lutein and antioxidant dietary supplementation on contrast sensitivity in age-related macular disease: a randomized controlled trial

The results suggest that 6 mg of lutein supplementation in combination with other antioxidants is not beneficial for this group, and further work is required to establish optimum dosage levels.

The effects of a lutein-based supplement on objective and subjective measures of retinal and visual function in eyes with age-related maculopathy – a randomised controlled trial

The statistically significant increase inmfERG latencies and the trend for reduced mfERG amplitudes on withdrawal are encouraging and may suggest a potentially beneficial effect of lutein-based supplementation in ARM-affected eyes.

Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: the CLEAR study.

L supplementation increases MPOD levels in early stage AMD patients, and according to the VA measurements, the progress of the disease might be slowed in some patients with augmented levels of MP.

TOZAL Study: An open case control study of an oral antioxidant and omega-3 supplement for dry AMD

Treatment with this unique nutritional supplement increased VA above the expected baseline decrease in the majority of patients in this population with dry macular degeneration, and the results of the TOZAL study agree with the LAST and CARMIS studies and are predictive for positive visual acuity outcomes in the AREDS II trial.

Macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: a randomized trial.

A supplement containing a fixed combination of lutein, zeaxanthin, and ω-3 LC-PUFAs during 12 months significantly improved plasma antioxidant capacity, circulating macular xanthophyll levels, and the optical density of the macular pigment.